Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcaemia: Results of a 3-year follow-up study

Clinical Endocrinology

Volumn 53, Issue 2, 2000, Pages 229-233

  Neunteufl, Thomas ^a   Heher, Sandra ^a   Prager, Gerhard ^a   Katzenschlager, Reinhold ^a   Abela, Claudette ^a   Niederle, Bruno ^a   Stefenelli, Thomas ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; ELECTROLYTE; GLYCERYL TRINITRATE;

ADULT; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW; BLOOD VESSEL REACTIVITY; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; MALE; PARATHYROIDECTOMY; PRIORITY JOURNAL; RISK FACTOR; VASCULAR DISEASE;

AGED; BRACHIAL ARTERY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; NITROPRUSSIDE; PARATHYROIDECTOMY; REGIONAL BLOOD FLOW; VASODILATION; VASODILATOR AGENTS;

EID: 0033900177     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.01076.x     Document Type: Article

References (32)

1. Assessment and treatment of endothelial dysfunction in humans
2. Serum calcium and survival in a large health screening program
3. Idiopathic arterial Calcification of infancy without intimal proliferation
4. Effect of parathyroid hormone on rat heart cells
5. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
6. Does mild, asymptomatic hyperparathyroidism require surgery?
7. The role of calcium in the pathogenesis of experimental arteriosclerosis
8. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease
9. Vascular Calcification in long-term haemodialysis patients in a single unit: A retrospective analysis
10. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers
11. Parathyroid hormone in coronary artery disease-results of a prospective study
12. Fatal cardiac calcifications secondary to primary hyperparathyroidism
13. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension
14. Primary hyperparathyroidism and the heart: Cardiac abnormalities correlated to clinical and biochemical data
15. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
16. Serum calcium: A new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years
17. Aortic and mitral valve calcification in patients with end-stage renal disease
18. Calcium phosphorus metabolism in dialysis patients with and without mitral anular calcium: Analysis of 30 patients
19. Impairment of endothelium-independent vasodilatation in patients with hypercalcaemia
20. Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men
21. Cardiac calcific deposits in patients with primary hyperparathyroidism: Preliminary results of a prospective echocardiographic study
22. Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow up
23. The natural history of adults with asymptotic hemodynamically significant aortic stenosis
24. Hyperparathyroidism associated with severe hypercalcaemia and myocardial calcification despite minimal bone disease
25. Effects of chronic hypercalcaemia on the heart. An analysis of 18 necropsy patients
26. Primary hyperparathyroidism and angina pectoris
27. Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes
28. Cardiac abnormalities in patients with primary hyperparathyroidism: Implications for follow-up
29. Primary Hyperparathyroidism: Incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy
30. Calcium-dependent fluorescence transients during ventricular fibrillation
31. Intracellular calcium transients during packing-induced ventricular fibrillation
32. Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism - An association